Related Experiment Video

Updated: Aug 16, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Family study on the polymorphisms of the sixth and seventh components (C6 and C7) of human complement: linkage and

K Tokunaga, G Dewald, K Omoto

    American Journal of Human Genetics
    |September 1, 1986
    PubMed

    Insights

    Genetic analysis of complement components C6 and C7 in Japanese families revealed close linkage between their loci. This study confirmed inheritance patterns for rare C6 variants and common C7 allotypes.

    Area of Science:

    • Immunogenetics
    • Human genetics
    • Complement system biology

    Background:

    • The complement system is crucial for innate and adaptive immunity.
    • Genetic variations in complement components can influence immune responses and disease susceptibility.
    • Understanding polymorphisms in complement factors C6 and C7 is important for human genetics.

    Purpose of the Study:

    • To investigate the genetic polymorphisms of the sixth (C6) and seventh (C7) complement components in a Japanese population.
    • To confirm the inheritance patterns of identified C6 and C7 variants.
    • To analyze the genetic linkage between the C6 and C7 loci.

    Main Methods:

    • Polyacrylamide gel isoelectric focusing (PAGIF) followed by immunoblotting was used to analyze C6 and C7 genetic variants.
    • Family material from a Japanese population was utilized for segregation and linkage analysis.
    • Lod score calculations and haplotype analysis were performed to assess linkage and disequilibrium.

    Main Results:

    • Three common and four rare alleles were identified at the C6 locus, including the novel variants M11 and B3.
    • Three common allotypes (C7 1, C7 2, C7 4) were classified for the C7 locus.
    • Close genetic linkage between the C6 and C7 loci was confirmed with a maximum lod score of 8.43 at phi = 0.
    • No significant linkage disequilibrium was observed between C6 and C7.

    Conclusions:

    • The study successfully characterized C6 and C7 genetic polymorphisms in the Japanese population.
    • Close genetic linkage between C6 and C7 loci provides insights into their chromosomal organization.
    • The findings contribute to the understanding of complement component genetics and their potential role in immune-related traits.

    More Related Videos

    A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene07:00

    A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

    Published on: April 1, 2019

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

    Published on: August 8, 2022

    Related Concept Videos

    Histone Variants at the Centromere02:30

    Histone Variants at the Centromere

    Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
    Comparing Copy Number Variations and SNPs02:26

    Comparing Copy Number Variations and SNPs

    Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
    Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
    Complementation Tests00:49

    Complementation Tests

    A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
    Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
    Single Nucleotide Polymorphisms-SNPs01:05

    Single Nucleotide Polymorphisms-SNPs

    A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
    Genome-wide Association Studies-GWAS01:11

    Genome-wide Association Studies-GWAS

    Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
    GWAS does not require the identification of the target gene involved in...
    Pharmacogenomics: Identification of New Drug Targets01:29

    Pharmacogenomics: Identification of New Drug Targets

    Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...